ID: ALA3954473

Max Phase: Preclinical

Molecular Formula: C19H18N4O3S

Molecular Weight: 382.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C(=O)c1ccc2c(c1)OCCO2)c1nc2c(s1)CCc1c-2cnn1C

Standard InChI:  InChI=1S/C19H18N4O3S/c1-22(18(24)11-3-5-14-15(9-11)26-8-7-25-14)19-21-17-12-10-20-23(2)13(12)4-6-16(17)27-19/h3,5,9-10H,4,6-8H2,1-2H3

Standard InChI Key:  KJEGZQWRSUZNHE-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydrolipoyl dehydrogenase 124 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 382.45Molecular Weight (Monoisotopic): 382.1100AlogP: 2.69#Rotatable Bonds: 2
Polar Surface Area: 69.48Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.00CX LogP: 2.71CX LogD: 2.71
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: -1.94

References

1.  (2015)  Compounds and methods for treating tuberculosis infection, 

Source

Source(1):